Japan
Showing 26 - 50 of 9,850
Acute Ischemic Stroke Trial in Japan (Redasemtide, Placebo)
Recruiting
- Acute Ischemic Stroke
- Redasemtide
- Placebo
-
Aichi, Japan
- +29 more
Jul 25, 2023
Nasal Polyps Trial in China, Japan, Russian Federation (Mepolizumab, Placebo, Standard of care)
Active, not recruiting
- Nasal Polyps
- Mepolizumab
- +2 more
-
Dongguan, Guangdong, China
- +60 more
Jan 10, 2023
Maviret in Adolescent Chronic Hepatitis C Virus
Recruiting
- Hepatitis C Virus (HCV)
-
Kariya-shi, Aichi, Japan
- +34 more
Oct 27, 2022
Assess Deucravacitinib Post-marketing Surveillance in Psoriasis
Not yet recruiting
- Psoriasis
-
Tosima-ku, Tokyo, JapanLocal Institution
Nov 22, 2022
Coronary Artery Disease Trial in Japan (Device: Paclitaxel-Coated PTCA Balloon Catheter, SeQuent Please Drug Eluting Balloon
Active, not recruiting
- Coronary Artery Disease
- Device: Paclitaxel-Coated PTCA Balloon Catheter
- SeQuent Please Drug Eluting Balloon Catheter with Paclitaxel
-
Kitakyushu, Fukuoka, Japan
- +13 more
Dec 2, 2022
Learn More About NTRK Gene Fusion Positive in Solid Tumor in
Not yet recruiting
- Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
- No Drug
-
Multiple Locations, JapanMany Locations
Mar 20, 2023
Primary Immunodeficiency Disease Trial in Japan (IGSC 20% infusion)
Active, not recruiting
- Primary Immunodeficiency Disease
- IGSC 20% infusion
-
Nagoya, Aichi, Japan
- +7 more
Jan 4, 2023
Pancreatic Fluid Collection, Pancreatitis, Pancreatic Pseudocyst Trial in Japan (Plastic stent, LAMS)
Not yet recruiting
- Pancreatic Fluid Collection
- +2 more
- Plastic stent
- LAMS
-
Aichi, Japan
- +25 more
Nov 9, 2023
(PMS) for the Long-term Safety of VAXZEVRIA
Active, not recruiting
- Prevention of Infectious Disease Caused by SARS-CoV-2
-
Chiba, Japan
- +5 more
Nov 24, 2022
B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma Trial in Canada, Japan (CTL019)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Diffuse Large B-cell Lymphoma
- CTL019
-
Hamilton, Ontario, Canada
- +41 more
Oct 17, 2022
Forxiga HF General Drug Use-Results Study
Active, not recruiting
- Heart Failure
-
Aichi, Japan
- +45 more
Jan 13, 2023
Effectiveness of Eosinophilic Granulomatosis With Polyangiitis
Active, not recruiting
- Churg-Strauss Syndrome
-
Aichi, Japan
- +33 more
Sep 20, 2022
Hypercholesterolemia Trial in Japan (K-877 0.2 mg/day (once daily), K-877 0.4 mg/day (once daily), Placebo (once daily))
Recruiting
- Hypercholesterolemia
- K-877 0.2 mg/day (once daily)
- +2 more
-
Aichi, Japan
- +14 more
Jun 20, 2023
Alzheimer, Early Onset Trial in Japan (LIPUS-Brain, Placebo)
Not yet recruiting
- Alzheimer Disease, Early Onset
- LIPUS-Brain
- Placebo
-
Nagoya, Aichi, Japan
- +11 more
Aug 1, 2023
Guillain-Barre Syndrome Trial in Japan (Eculizumab, Placebo)
Completed
- Guillain-Barre Syndrome
- Eculizumab
- Placebo
-
Bunkyo-ku, Japan
- +25 more
Aug 26, 2022
All-Case Surveillance of Ofev in Patients With IPF in Japan
Recruiting
- Idiopathic Pulmonary Fibrosis
-
Multiple Locations, Japan(unnamed)
Jan 23, 2023
Disease Activity and Adverse Events of Rinvoq in Adult Moderate
Recruiting
- Ulcerative Colitis
-
Kurume-shi, Fukuoka, Japan
- +4 more
Mar 17, 2023